Sat, Dec 20, 2014, 1:59 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • rehdvm2004 rehdvm2004 Jul 23, 2013 10:06 AM Flag

    The extra money from the 6 million+ shares of stock is spoken for . . .

    to get Arikace into a world market. I still look for the breakthrough therapy as being efficacious NTM treatment. The CF/Pa will be competitive with the other inhalationals.

    But the next breakthrough is just sitting there screaming for a clinical trial. If you look at the ClinicalTrials website and search "inhalation AND antituberculosis drugs" . . . there is only one study of any significance. Thailand is performing a study on inhalational forms of the CDC recommended rotation of antituberculosis drugs. Those drugs should also be tried in INSM's IP liposome to see if the drugs "stick" in the fixed macrophages of the conducting airways and the alveolar macrophages. These are the sites where TB, not unlike NTM "set up housekeeping."

    GLTAL

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
16.42+0.37(+2.31%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.